Search
+
    SEARCHED FOR:

    ROCHE

    Drugmakers tap China AI app boom to reach doctors as crackdown upends marketing

    As scrutiny intensifies, Chinese pharmaceutical companies are shifting gears toward digital marketing initiatives. Traditional face-to-face communications are waning, prompting the industry to embrace AI-fueled applications for connecting with healthcare providers. These tools facilitate compliant relationships, sparking partnerships among health-tech firms to disseminate clinical information through digital channels. This marks a pivotal change in marketing dynamics within the pharmaceutical landscape.

    After freezer attacks and fake nuclear alerts, Europe hit by wave of bomb threats targeting flights: Which flights were affected and who's behind it?

    In light of recent bomb threats troubling various European nations, numerous airlines including Ryanair, Wizz Air, and Finnair were forced to reroute flights and implement military escorts. Authorities found that the threats were ultimately empty, but heightened vigilance remains with ongoing cyberattacks and drone activity demanding attention. Governments are now urging citizens to stockpile emergency supplies as a precautionary measure amidst these escalated security challenges.

    Hrithik Roshan lives in a Rs 100-crore, 3-floor, 38,000 sq ft Mumbai home: House has vending machine, a grand piano, private theatre giant telescope and gym

    The architectural wonder that is Hrithik Roshan's Juhu home is a reflection of his opulent lifestyle and sophisticated taste. In addition to becoming a well-known actor and dancer, the Bollywood star has established himself as a successful businessman. His gorgeous home facing the sea in Mumbai's Juhu area is still his most valuable asset, though.

    Inside Demi Lovato's $7 million Studio City modern farmhouse in Los Angeles

    Demi Lovato’s $7 million Studio City home is a modern farmhouse. It has a psychedelic interior and a recording studio. The 8,500 sq ft home has 6 bedrooms, 9 bathrooms. The property has a home theatre, a gym, a saltwater pool and a guest house. The home was designed in collaboration with Argyle Design founders Kat Bell and James Drew.

    AI halves drug discovery times, but =trial bottleneck remains a costly reality

    Novo Nordisk, Sanofi and Dr Reddy’s Laboratories are among the companies exploring applications ranging from drug discovery to laboratory automation and research.

    L'Oreal bets on quick commerce, local products to accelerate India growth

    L'Oreal is seeing substantial growth in its Indian market, supported by enhanced team capabilities and localization strategies. The company's consumer products division reported double-digit growth, particularly in haircare and skincare. L'Oreal is expanding its skincare brands CeraVe and La Roche-Posay into new cities to meet rising consumer demand. Additionally, L'Oreal has acquired a majority stake in Innovist to boost its digital-first marketing approach in India.

    • How France's worst rioting in years erupted and how the government responded

      Recent rioting in France has led to significant violence, with clashes between police and protesters occurring in major cities. Thousands of arrests were made amid widespread looting and damage to businesses. Protests against rising living costs and poor school conditions occurred alongside the violence. President Macron has condemned the unrest and pledged an uncompromising response to the riots.

      The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reach

      For millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that remain out of reach, the affordability crisis runs deep. A proposed cap may help, but question remains if it will be enough to change the picture.

      WEF could appoint Lagarde as early as November, sources say

      Christine Lagarde is likely to be appointed as the chair of the World Economic Forum next month. This change would require her to step down from her position as European Central Bank chief. Following Lagarde's exit, there will be a reshuffle within the ECB due to upcoming political changes in France. The WEF board is scheduled to meet on November 2 to discuss her potential role.

      Biocon settles US patent dispute with Roche's Genentech, eyes 2027 Perjeta biosimilar launch

      Biocon announced a settlement with Genentech over its biosimilar, Pebrilzo, of the cancer drug Perjeta. The agreement allows Biocon to launch Pebrilzo in early 2027 in the UK and EU, and in late 2028 in the US. In response to Genentech's patent infringement suit, the New Jersey court dismissed the case at Genentech's request. The details of the settlement agreement remain confidential between the companies involved.

      Roche highlights the urgent need for a transformation in global healthcare to effectively tackle chronic diseases. Jorg Rupp pointed out that existing healthcare infrastructures are largely reactive, falling short in proactively addressing the rise of non-communicable diseases. This burgeoning issue not only challenges health systems but also imposes heavy financial demands. Governments must begin viewing healthcare as a crucial investment aimed at enhancing health outcomes.

      European pharma chiefs warn region risks losing ground to America, China

      Drugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a disparity in access with the US, unless the region's healthcare systems agree to boost spending.

      Celldex shares slip 15% as safety concerns cloud skin drug trial win

      (Rewrites throughout to add company comments, adds shares in paragraph 2, analyst comment in paragraph 5)- Celldex Therapeutics said on Tuesday its experimental

      Global funds, same tech bet? The diversification trap Indian investors may miss

      Many Indian investors mistakenly believe they diversify their portfolios by adding foreign countries. However, numerous global indices often revolve around similar technology narratives, particularly in semiconductors. To achieve real diversification, investors must grasp the fundamental earnings drivers. Exploring Europe and Japan can unveil distinct economic pathways, offering a refreshing contrast. A thorough assessment of concentration risks and market dynamics is vital when engaging in international investments.

      Sunscreen grows from niche to staple on India’s beauty shelf as buyers triple

      Sunscreen use in India has more than tripled, reaching 14.3 million households. This growth is fueled by hotter weather and increased consumer awareness about sun protection. The market is expanding beyond major cities, with rural penetration showing significant increases. Both mass and premium brands are catering to diverse consumer needs and price points. Sunscreen's role is shifting from seasonal to daily skincare and anti-aging.

      Anthropic quietly sets up biology lab as it ramps AI drug program

      At a time when fears of AI are gripping the public, the startup has built a wet lab, or place for physical experiments, in the San Francisco Bay Area, two people familiar with the matter said. Anthropic has said it wants to unlock treatments for rare diseases, and its biology work has gone beyond "in silico" or computer evaluations.

      In 1984, Lincoln's handwritten final public address emerged from a secret compartment in an antique table; the forgotten manuscript later sold for $231,000

      A remarkable manuscript discovery at New York City’s Morris-Jumel Mansion brought an overlooked piece of Revolutionary-era history back into focus. In 2013, archives intern Emilie Gruchow was cataloguing old manuscripts in the mansion’s hot attic when she found fragments of a document misfiled among the papers of 18th-century doctor Nicholas Roche. She recognised the text as a draft of “The Twelve United Colonies, by their Delegates in Congress, to the Inhabitants of Great Britain.” Experts authenticated the manuscript and linked its primary authorship to Robert R. Livingston. The museum later sold the 12-page document at auction for $912,500.

      Delhi HC allows Natco Pharma to launch risdiplam, rejects Roche plea

      The Delhi High Court has permitted Natco Pharma to launch its affordable generic version of risdiplam, a crucial drug for spinal muscular atrophy. This decision overturns a previous stay, allowing Natco to offer the medication at a significantly lower price than Swiss multinational Roche's imported Evrysdi. Roche expressed disappointment, emphasizing the importance of patent protection for innovation.

      Who was Rosie Roche? 20-year-old cousin of Prince William and Prince Harry found dead; details so far

      Rosie Roche, a 20-year-old relative of Prince William and Harry, tragically passed away at her Wiltshire home. The Durham University student, granddaughter of Princess Diana’s uncle, was discovered by her family while preparing for a holiday. Authorities have deemed the death non-suspicious, with no signs of foul play. An inquest is underway to determine the circumstances surrounding her demise.

      Roche made over 100 times the cost of a medicine that it sold in India, calculations show; company defends itself

      A recent report in The Times of India reveals that Roche may have profited immensely from risdiplam, a drug for spinal muscular atrophy (SMA), potentially earning 115 times its clinical trial expenses. Knowledge Ecology International estimates trial costs at $50 million, while Roche's risdiplam revenue reached $5.8 billion. Roche defends its pricing, citing unsuccessful projects and ongoing research.

      Roche Pharma India to appoint Rajwinder Mehdwan as country general manager

      Roche Pharma India has announced that Rajwinder Mehdwan will take over as the country general manager from April 1, 2025, replacing V Simpson Emmanuel. Rajji brings over 20 years of healthcare industry experience and has held various leadership roles at Roche and Johnson & Johnson.

      Roche Diabetes starts manufacturing top glucose monitoring device in India

      In addition to catering to the India market, Roche will use India as a hub to also supply Accu-Chek Active meters to Roche US and Germany in order to cater to the demands across the world. Roche said the first batch of made in India glucometers are already available in the market across the country.

      Roche Pharma India expands partnership with Cipla for key oncology medicines

      Roche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distribution of its trademark oncology drugs - trastuzumab (Herclon), bevacizumab (Avastin) and rituximab (Ristova) in India," the company said in a statement.

      Roche India head Lara Bezerra set to exit

      A Roche India spokesperson confirmed the development and said an announcement for a new India head will be made soon. “Dec. 1 will be the date for Lara to end the assignment. During her tenure at Roche India, Lara successfully led the organization with passion and commitment and shaped the culture of the organization,”the statement added.

      Cipla ties up with Roche to sell 2 cancer drugs in India

      The pharma major will distribute Tocilizumab and Syndyma -- the second brand of Roche's cancer therapy bevacizumab -- in India.

      Lara Bezerra to take over as Roche Products India MD

      Lara has over 24 years of experience in the pharmaceutical industry and was earlier the general manager of Roche Venezuela.

      Swiss pharma company Roche faces probe for blocking cheaper cancer drugs

      The probe has been ordered in response to a complaint filed by Bengaluru-based Biocon and US firm Mylan, who together sell biosimilars of the drug in over a dozen countries, including India, at a price lower by over 25% than Roche's .

      Court defers decision on Roche's plea against Zydus' cancer drug

      Roche sued Zydus Cadila and the DCGI last week, alleging that the Indian company launched its product, Vivitra, in the country without generating its own clinical trial data.

      Now, Roche takes Zydus Cadila to court over breast cancer drug

      The petition states the approval of Cadila’s drug as a biosimilar has caused Roche “irreparable damage” in violation of applicable law for testing and approval of biosimilar drugs.

      Load More
    The Economic Times
    BACK TO TOP